Related Experiment Video
Updated: Aug 18, 2026

Reduced Itraconazole Concentration and Durations Are Successful in Treating Batrachochytrium dendrobatidis Infection in Amphibians
Published on: March 14, 2014
Reversible dilated cardiomyopathy associated with amphotericin B treatment
Ioannis Moyssakis1, Theodoros P Vassilakopoulos, Nikolaos V Sipsas
1Department of Cardiology, Laikon General Hospital, Athens, Greece.
Abstract:
We report two patients, who developed dilated cardiomyopathy and subsequent congestive heart failure after treatment with amphotericin B (AmB). The echocardiographic findings and the symptoms of heart failure resolved after the discontinuation of the drug. The clinical data from our cases and two similar cases reported in the literature suggest that the presence of other factors predisposing to cardiac dysfunction may facilitate the occurrence of this rare side effect.
Related Concept Videos
Antifungal Agents
Cryptococcal Meningitis
Cardiomyopathy V: Interprofessional Care
Cardiomyopathy II: Dilated Cardiomyopathy
Cardiomyopathy IV: Restrictive Cardiomyopathy
Heart Failure Drugs: Inotropic Agents
